R Nu6-919P: A Potential Drug Target or Biomarker (G106479972)
R Nu6-919P: A Potential Drug Target or Biomarker
RNA, U6 small nuclear 919, pseudogene (R Nu6-919P) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. It is a small RNA molecule that is expressed in different cell types of the human body, including the brain, heart, and liver.
R Nu6-919P is characterized by its unique sequence, which consists of 91 amino acids. It is composed of a single exon that is located on the U6 class of RNA molecules. This class of RNA molecules are characterized by their ability to interact with protein-coding genes, as well as their role in regulating gene expression.
One of the reasons why R Nu6-919P has potential as a drug target is its unique expression pattern. It is primarily expressed in the brain, heart, and liver, which are all critical organs for maintaining the health and function of the human body. This suggests that R Nu6-919P may play a crucial role in the development and progression of various neurological and cardiovascular diseases.
In addition to its unique expression pattern, R Nu6-919P has also been shown to play a role in the regulation of gene expression. Studies have shown that R Nu6-919P can interact with protein-coding genes and that it can modulate the activity of these genes. This suggests that R Nu6-919P may be a valuable drug target for the treatment of a variety of diseases.
Another potential reason why R Nu6-919P has potential as a drug target is its unique structure. The sequence of R Nu6-919P is highly conserved across different species, which suggests that it may be a universal protein. This makes it a promising candidate for the development of a broad range of therapeutic compounds that can be used to treat a variety of diseases.
In conclusion, R Nu6-919P is a promising candidate as a drug target or biomarker due to its unique expression pattern, its role in regulating gene expression, and its unique structure. Further research is needed to fully understand the potential of R Nu6-919P as a therapeutic compound.
Protein Name: RNA, U6 Small Nuclear 919, Pseudogene
More Common Targets
RNU6-947P | RNU6-951P | RNU6-968P | RNU6-98P | RNU6-990P | RNU6ATAC | RNU6ATAC18P | RNU6V | RNU7-1 | RNU7-102P | RNU7-11P | RNU7-13P | RNU7-156P | RNU7-16P | RNU7-180P | RNU7-26P | RNU7-2P | RNU7-34P | RNU7-35P | RNU7-45P | RNU7-57P | RNU7-61P | RNU7-72P | RNU7-76P | RNVU1-1 | RNVU1-18 | RNVU1-19 | RNVU1-20 | RNVU1-7 | RNY1 | RNY3 | RNY3P3 | RNY4 | RNY4P10 | RNY4P13 | RNY4P18 | RNY4P19 | RNY4P20 | RNY4P25 | RNY5 | RNY5P5 | RO60 | ROBO1 | ROBO2 | ROBO3 | ROBO4 | ROCK1 | ROCK1P1 | ROCK2 | ROCR | Rod cGMP phosphodiesterase 6 | ROGDI | ROM1 | ROMO1 | ROPN1 | ROPN1B | ROPN1L | ROR1 | ROR1-AS1 | ROR2 | RORA | RORA-AS1 | RORB | RORC | ROS1 | Roundabout homolog receptor | RP1 | RP1L1 | RP2 | RP9 | RP9P | RPA1 | RPA2 | RPA3 | RPA3P1 | RPA4 | RPAIN | RPAP1 | RPAP2 | RPAP3 | RPAP3-DT | RPE | RPE65 | RPEL1 | RPF1 | RPF2 | RPGR | RPGRIP1 | RPGRIP1L | RPH3A | RPH3AL | RPH3AL-AS1 | RPIA | RPL10 | RPL10A | RPL10AP10 | RPL10AP12 | RPL10AP3 | RPL10AP6 | RPL10AP7